The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 29, 2025
Filed:
Nov. 28, 2019
Centre Leon Berard, Lyons, FR;
Centre National DE LA Recherche Scientifique (Cnrs), Paris, FR;
Universite Claude Bernard Lyon 1, Villeurbanne, FR;
Institut National DE LA Sante ET DE LA Recherche Medicale (Inserm), Paris, FR;
Universite Grenoble Alpes, Saint Martin d'Heres, FR;
Universite DE Caen Normandie, Caen, FR;
Marc Billaud, Lyons, FR;
Renaud Prudent, Renage, FR;
Martine Cordier-Bussat, Chassieu, FR;
Eric Fontaine, Bernin, FR;
Patrick Dallemagne, Seulline, FR;
Peggy Suzanne, Cairon, FR;
Sylvain Rault, Moult, FR;
CENTRE LEON BERARD, Lyons, FR;
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), Paris, FR;
UNIVERSITE CLAUDE BERNARD LYON 1, Villeurbanne, FR;
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), Paris, FR;
UNIVERSITE GRENOBLE ALPES, Saint Martin d'Heres, FR;
UNIVERSITE DE CAEN NORMANDIE, Caen, FR;
Abstract
The invention relates to compounds of formula (I) as follows: (I) wherein Xand X, identical or different, are NRor a sulfur atom, Y is a group (C-C)alkanediyl, Arand Ar, identical or different, are an aryl group optionally substituted by one or several groups selected from a halogen atom, a (C-C) alkyl, —OR, —NRRand —COOR' with Rand R, independently of each other, are a hydrogen atom, a (C--C) alkyl group or a —CORgroup, Rand R′ independently of each other, are a hydrogen atom or a (C-C) alkyl group, and Ris a hydrogen atom or a (C-C)alkyl group, or a pharmaceutically acceptable salt and/or solvate thereof, in particular for use in cancer treatment.